PubMed ID,Title,Publication Date,Non-Academic Author(s),Company Affiliation(s),Corresponding Author(s) Email
40079167,Developing and Implementing a Colorectal Cancer Screening Program in Uganda: Stakeholder Perceived Barriers and Opportunities.,2025,Brian T Johnston,"Deartment of Gastroenterology, Belfast Health and Social Care Trust, Belfast, UK.",N/A
40079105,Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.,2025,"Po-Nan Wang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Arnaud Lesegretain, Herve Dombret","Chang Gung Medical Foundation, Linkou., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Hopital Saint-Louis, Assistance Publique-Hopitax de Paris, Universite Paris Cite.",N/A
40079097,Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up.,2025,"Ryan S Basom, Qian Vicky Wu","Fred Hutchinson Cancer Center, Seattle, WA., Fred Hutchinson Cancer Center, Seattle, WA.",N/A
40079066,MXenes and MXene-based composites for biomedical applications.,2025,Parvej Alam,"Space and Reslinent Research Unit, Centre Tecnol√≤gic de Telecomunicacions de Catalunya Castelldefels, Spain. smishra@cttc.es.",N/A
40078999,Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy.,2025,"Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, Nancy Chau, Natasja Nielsen Viller, Lisa D S Johnson, Emma Linderoth, Christopher P Dillon, Keith Abayasiriwardana, Clare Lees, Mark Wong, Megan M Kaneda, Robert A Uger, Gloria H Y Lin","Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States.",N/A
40078986,Impact of menopause and age on breast density and background parenchymal enhancement in dynamic contrast-enhanced magnetic resonance imaging.,2025,"Belinda Curpen, Ellen Warner","Sunnybrook Health Sciences Centre, Division of Breast Imaging, Toronto, Ontario, Canada., Sunnybrook Odette Cancer Centre, Division of Medical Oncology and Hematology, Toronto, Ontario, Canada.",N/A
